Pill cam could spot hidden colon cancers in blood infection patients
NCT ID NCT06919068
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a tiny camera in a pill (colon capsule endoscopy) can find colorectal cancer or precancerous growths in people who have had a bloodstream infection with certain gut bacteria. About 100 adults will swallow the camera 4-8 weeks after leaving the hospital. The goal is to see how common hidden colon tumors are in this group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- PillCam Colon 2 (colon capsule endoscopy)
- What this could lead to
- If successful, this could show that colon capsule endoscopy is a useful tool to find hidden colorectal cancers in patients with certain bloodstream infections.
- What could go wrong
- This is a small, early observational study, not a treatment trial. The capsule may miss some tumors, and results may not apply to the general population.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAEROBIC INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Odense University Hospital
RECRUITINGOdense, 5000, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Why are more younger adults getting colorectal cancer? a national study digs into the data
- New drug combo aims to boost response in Hard-to-Treat colorectal cancer
- First-in-Class cancer drug targets Hard-to-Treat tumors
- New pill targets Hard-to-Treat cancers with a specific gene mutation
- AI eye on cancer: robot helps spot hidden polyps
- New hope for Hard-to-Treat colorectal cancer? drug combo trial launches